Clinical Trial Update: Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of an antiarrhythmic drug to treat atrial fibrillation in patients with pacemakers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: ARYx Therapeutics | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED